India's Nivaan Care Secures $7M to Revolutionize Chronic Pain Management
January 31, 2026, 3:56 pm
Nivaan Care, an innovative Indian health tech startup, has successfully closed a $7 million Series A funding round. Sorin Investments led the substantial investment. This new capital is earmarked for aggressive expansion. Nivaan will broaden its specialized chronic pain management clinic network across multiple Indian cities. The company focuses on non-surgical, minimally invasive procedures. It targets an estimated 270 million Indians suffering from chronic pain. India's pain management market remains largely underserved. Nivaan aims to bridge this critical gap. The company projects growth from 15 to 60-75 clinics within four to five years. This significant funding round highlights escalating investor confidence in India's burgeoning health tech sector. Nivaan's integrated care model promises to standardize and scale crucial specialty healthcare services, delivering measurable patient improvements nationwide.
Nivaan Care, a New Delhi-based healthcare startup, recently announced a significant $7 million Series A funding round. This capital infusion propels its mission. The company aims to transform chronic pain management across India. Sorin Investments led the crucial round. Existing investors also participated. W Health Ventures, Endiya Partners, and Rebright Partners continued their support. This latest funding brings Nivaan Care's total raised capital to $12 million since its 2023 inception.
The startup will deploy these funds strategically. Expansion of its clinic network is a top priority. Nivaan plans to reach more Indian cities. It will also strengthen clinical and operating infrastructure. Enhancing its minimally invasive pain management procedures remains a key objective. The company focuses on an immense, underserved market.
Chronic pain represents a staggering public health challenge in India. An estimated 270 million Indians grapple with persistent pain. This figure continues to climb. Sedentary lifestyles contribute significantly to its rise. Increased device usage and reduced mobility fuel the problem. Despite widespread suffering, specialized care remains fragmented. Organized pain management options are severely limited.
A stark contrast exists between India and developed nations. The United States boasts thousands of interventional pain management clinics. India, in comparison, has fewer than 200. This disparity underscores a critical healthcare gap. Nivaan Care seeks to bridge this divide. Its leaders recognize a market opportunity. They compare it to the early days of IVF in India. That specialty also began small. It later scaled dramatically.
Nivaan Care champions a non-surgical approach. The company specializes in minimally invasive treatments. It addresses chronic pain across the body. Back, neck, and knee conditions are common targets. Many patients fear surgery. Up to 80% of prescribed surgeries are not performed in India. This reluctance stems from fear, uncertainty, and invasive concerns. Nivaan provides a compelling alternative.
The company employs a multidisciplinary care model. This integrated strategy is fundamental to its success. Pain physicians lead the treatment. Physiotherapists offer crucial rehabilitative support. Care coordinators ensure seamless patient journeys. Together, they deliver comprehensive care. This approach standardizes diagnosis, treatment, and follow-up protocols.
Nivaan’s platform builds an evidence-led middle layer of care. It fills a void between basic physiotherapy and invasive surgery. This model delivers measurable improvements for patients. It stands apart from generalist care settings. There, chronic pain treatment can be inconsistent. Nivaan's focus on specialized clinicians ensures consistent quality. Its outcomes-driven framework defines its impact.
The company has already established a notable presence. It operates clinics across Delhi-NCR, Mumbai, Jaipur, and Lucknow. Nivaan currently maintains approximately 15 specialized centers. Its operational reach continues to grow. These clinics serve a burgeoning patient base. The traction achieved is significant. Nivaan has conducted over 40,000 consultations. It has performed around 5,000 minimally invasive procedures.
This strong performance confirms Nivaan’s product-market fit. The business model is proven. The company now focuses on aggressive scaling. Plans project an expansion from 15 to 60-75 clinics. This ambitious growth will unfold over the next four to five years. This expansion targets a nationwide footprint. It will make specialist pain management more accessible.
Investors recognize Nivaan’s unique position. Sorin Investments highlights the opportunity. Pain management is a large, underserved specialty. Traditional hospital setups struggle to scale it. Nivaan offers an organized, repeatable solution. The company’s ability to centralize care delivery is crucial. Its coordination of patient journeys drives efficiency. Combining multiple treatment disciplines under one platform makes specialty care repeatable.
The investment underscores rising confidence in India’s health tech sector. Platforms focused on specialty services attract significant capital. These companies demonstrate consistent outcomes. They also scale access in large, underserved categories. Nivaan’s leaders are building a category-defining model. It aims to revolutionize structured chronic pain management.
Leaders within Sorin Investments emphasize Nivaan’s strengths. The company's clinical depth impressed them. Its focus on consistent quality was a key factor. The team's ability to build and scale specialized healthcare services without sacrificing standardization proved compelling. This approach offers a clear first-mover advantage. Nivaan’s full-stack solution, backed by strong clinical acumen, sets it apart.
The future for Nivaan Care is clear. The company will accelerate its expansion. New locations like Bengaluru are on the horizon. Platform capabilities will deepen. The operational backbone for expansion into select satellite cities will be built. Nivaan aims to continuously innovate patient-first solutions. These solutions are specifically designed for India’s unique needs. This investment marks a pivotal moment. It signals a shift in chronic pain management in India. Nivaan Care is poised to lead this transformation. Its integrated, multidisciplinary model will deliver superior patient outcomes nationwide.
Nivaan Care, a New Delhi-based healthcare startup, recently announced a significant $7 million Series A funding round. This capital infusion propels its mission. The company aims to transform chronic pain management across India. Sorin Investments led the crucial round. Existing investors also participated. W Health Ventures, Endiya Partners, and Rebright Partners continued their support. This latest funding brings Nivaan Care's total raised capital to $12 million since its 2023 inception.
The startup will deploy these funds strategically. Expansion of its clinic network is a top priority. Nivaan plans to reach more Indian cities. It will also strengthen clinical and operating infrastructure. Enhancing its minimally invasive pain management procedures remains a key objective. The company focuses on an immense, underserved market.
Chronic pain represents a staggering public health challenge in India. An estimated 270 million Indians grapple with persistent pain. This figure continues to climb. Sedentary lifestyles contribute significantly to its rise. Increased device usage and reduced mobility fuel the problem. Despite widespread suffering, specialized care remains fragmented. Organized pain management options are severely limited.
A stark contrast exists between India and developed nations. The United States boasts thousands of interventional pain management clinics. India, in comparison, has fewer than 200. This disparity underscores a critical healthcare gap. Nivaan Care seeks to bridge this divide. Its leaders recognize a market opportunity. They compare it to the early days of IVF in India. That specialty also began small. It later scaled dramatically.
Nivaan Care champions a non-surgical approach. The company specializes in minimally invasive treatments. It addresses chronic pain across the body. Back, neck, and knee conditions are common targets. Many patients fear surgery. Up to 80% of prescribed surgeries are not performed in India. This reluctance stems from fear, uncertainty, and invasive concerns. Nivaan provides a compelling alternative.
The company employs a multidisciplinary care model. This integrated strategy is fundamental to its success. Pain physicians lead the treatment. Physiotherapists offer crucial rehabilitative support. Care coordinators ensure seamless patient journeys. Together, they deliver comprehensive care. This approach standardizes diagnosis, treatment, and follow-up protocols.
Nivaan’s platform builds an evidence-led middle layer of care. It fills a void between basic physiotherapy and invasive surgery. This model delivers measurable improvements for patients. It stands apart from generalist care settings. There, chronic pain treatment can be inconsistent. Nivaan's focus on specialized clinicians ensures consistent quality. Its outcomes-driven framework defines its impact.
The company has already established a notable presence. It operates clinics across Delhi-NCR, Mumbai, Jaipur, and Lucknow. Nivaan currently maintains approximately 15 specialized centers. Its operational reach continues to grow. These clinics serve a burgeoning patient base. The traction achieved is significant. Nivaan has conducted over 40,000 consultations. It has performed around 5,000 minimally invasive procedures.
This strong performance confirms Nivaan’s product-market fit. The business model is proven. The company now focuses on aggressive scaling. Plans project an expansion from 15 to 60-75 clinics. This ambitious growth will unfold over the next four to five years. This expansion targets a nationwide footprint. It will make specialist pain management more accessible.
Investors recognize Nivaan’s unique position. Sorin Investments highlights the opportunity. Pain management is a large, underserved specialty. Traditional hospital setups struggle to scale it. Nivaan offers an organized, repeatable solution. The company’s ability to centralize care delivery is crucial. Its coordination of patient journeys drives efficiency. Combining multiple treatment disciplines under one platform makes specialty care repeatable.
The investment underscores rising confidence in India’s health tech sector. Platforms focused on specialty services attract significant capital. These companies demonstrate consistent outcomes. They also scale access in large, underserved categories. Nivaan’s leaders are building a category-defining model. It aims to revolutionize structured chronic pain management.
Leaders within Sorin Investments emphasize Nivaan’s strengths. The company's clinical depth impressed them. Its focus on consistent quality was a key factor. The team's ability to build and scale specialized healthcare services without sacrificing standardization proved compelling. This approach offers a clear first-mover advantage. Nivaan’s full-stack solution, backed by strong clinical acumen, sets it apart.
The future for Nivaan Care is clear. The company will accelerate its expansion. New locations like Bengaluru are on the horizon. Platform capabilities will deepen. The operational backbone for expansion into select satellite cities will be built. Nivaan aims to continuously innovate patient-first solutions. These solutions are specifically designed for India’s unique needs. This investment marks a pivotal moment. It signals a shift in chronic pain management in India. Nivaan Care is poised to lead this transformation. Its integrated, multidisciplinary model will deliver superior patient outcomes nationwide.